CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
REVENUES	$ 54,693	$ 34,240	$ 21,078
COST OF GOODS SOLD	(10,895)	(9,302)	(15,231)
RESEARCH AND DEVELOPMENT EXPENSES	(44,693)	(35,534)	(32,170)
Less - grants	77	2,204	3,336
RESEARCH AND DEVELOPMENT EXPENSES, NET	(44,616)	(33,330)	(28,834)
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES	(9,899)	(10,916)	(11,530)
OPERATING LOSS	(10,717)	(19,308)	(34,517)
FINANCIAL EXPENSES	(7,966)	(7,685)	(9,725)
FINANCIAL INCOME	407	536	188
LOSS FROM CHANGE IN FAIR VALUE OF CONVERTIBLE NOTES EMBEDDED DERIVATIVE	0	0	(38,061)
LOSS ON EXTINGUISHMENT OF CONVERTIBLE NOTES	0	0	(1,325)
FINANCIAL EXPENSES - NET	(7,559)	(7,149)	(48,923)
NET LOSS FOR THE YEAR	$ (18,276)	$ (26,457)	$ (83,440)
NET LOSS PER SHARE OF COMMON STOCK - BASIC AND DILUTED	$ (1.23)	$ (1.80)	$ (6.37)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE-BASIC AND DILUTED	14,838,213	14,713,518	13,108,596
Goods [Member]
REVENUES	$ 15,866	$ 8,978	$ 19,242
License and R&D Services [Member]
REVENUES	$ 38,827	$ 25,262	$ 1,836